Cipla appoints Dr. Peter Mugyenyi as an Independent Director on the Board

Cipla appoints Mr.Sameer Goel as Country Head – India

Cipla announces Q2 FY1314 Unaudited Consolidated Financial Results

Cipla announces Q1 FY 1314 Unaudited Financial Results

Cipla India concludes the deal with Cipla Medpro South Africa

Cipla announces Q4 FY 1213 Unaudited Financial Results

Cipla launches the first Biosimilar of Etanercept in India under the brand name ‘ETACEPT’ for the treatment of Rheumatic Disorders

Cipla announces Result of Postal Ballot

Cipla announces Q3 FY 1213 Unaudited Financial Results

Cipla appoints a new Chief Executive Officer

Subscribe to